Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 4
2004 9
2005 7
2006 8
2007 5
2008 5
2009 8
2010 9
2011 13
2012 6
2013 8
2014 10
2015 10
2016 7
2017 10
2018 8
2019 11
2020 10
2021 16
2022 9
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial.
Carvajal RD, Butler MO, Shoushtari AN, Hassel JC, Ikeguchi A, Hernandez-Aya L, Nathan P, Hamid O, Piulats JM, Rioth M, Johnson DB, Luke JJ, Espinosa E, Leyvraz S, Collins L, Goodall HM, Ranade K, Holland C, Abdullah SE, Sacco JJ, Sato T. Carvajal RD, et al. Among authors: espinosa e. Nat Med. 2022 Nov;28(11):2364-2373. doi: 10.1038/s41591-022-02015-7. Epub 2022 Oct 13. Nat Med. 2022. PMID: 36229663 Free PMC article. Clinical Trial.
Sequence of therapies for advanced BRAFV600E/K melanoma.
Gonzalez-Cao M, Rosell R, Martin Algarra S, Puertolas T, Espinosa E. Gonzalez-Cao M, et al. Among authors: espinosa e. Ann Transl Med. 2023 Mar 31;11(6):270. doi: 10.21037/atm-23-165. Epub 2023 Feb 14. Ann Transl Med. 2023. PMID: 37082692 Free PMC article. No abstract available.
[Prognostic factors of early breast cancer].
Almagro E, González CS, Espinosa E. Almagro E, et al. Among authors: espinosa e. Med Clin (Barc). 2016 Feb 19;146(4):167-71. doi: 10.1016/j.medcli.2014.12.019. Epub 2015 Feb 26. Med Clin (Barc). 2016. PMID: 25726309 Review. Spanish.
Thromboembolic disease in cancer patients.
Hindi N, Cordero N, Espinosa E. Hindi N, et al. Among authors: espinosa e. Support Care Cancer. 2013 May;21(5):1481-6. doi: 10.1007/s00520-013-1742-6. Epub 2013 Feb 21. Support Care Cancer. 2013. PMID: 23430009 Review.
Treatment algorithms in stage IV melanoma.
Espinosa E, Grob JJ, Dummer R, Rutkowski P, Robert C, Gogas H, Kefford R, Eggermont AM, Martin Algarra S, Hauschild A, Schadendorf D. Espinosa E, et al. Am J Ther. 2015 Jan-Feb;22(1):61-7. doi: 10.1097/MJT.0b013e31829e885c. Am J Ther. 2015. PMID: 24413374 Free article. Review.
Gp-100 as a Novel Therapeutic Target in Uveal Melanoma.
Martinez-Perez D, Viñal D, Solares I, Espinosa E, Feliu J. Martinez-Perez D, et al. Among authors: espinosa e. Cancers (Basel). 2021 Nov 27;13(23):5968. doi: 10.3390/cancers13235968. Cancers (Basel). 2021. PMID: 34885078 Free PMC article. Review.
Melanoma: diagnosis, staging, and treatment. Consensus group recommendations.
Berrocal A, Cabañas L, Espinosa E, Fernández-de-Misa R, Martín-Algarra S, Martínez-Cedres JC, Ríos-Buceta L, Rodríguez-Peralto JL. Berrocal A, et al. Among authors: espinosa e. Adv Ther. 2014 Sep;31(9):945-60. doi: 10.1007/s12325-014-0148-2. Epub 2014 Aug 22. Adv Ther. 2014. PMID: 25145549 Review.
Who benefits most from adjuvant interferon treatment for melanoma?
Gogas H, Abali H, Ascierto PA, Demidov L, Pehamberger H, Robert C, Schachter J, Eggermont AM, Hauschild A, Espinosa E. Gogas H, et al. Among authors: espinosa e. Am J Ther. 2015 Jan-Feb;22(1):54-60. doi: 10.1097/MJT.0b013e31829e883d. Am J Ther. 2015. PMID: 24176884 Review.
179 results